Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review
Open Access
- 1 November 2012
- journal article
- review article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 105 (2), 145-149
- https://doi.org/10.1016/j.radonc.2012.09.008
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Individualized Dose Prescription for Hypofractionation in Advanced Non-Small-Cell Lung Cancer Radiotherapy: An in silico TrialInternational Journal of Radiation Oncology*Biology*Physics, 2012
- The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancerRadiotherapy and Oncology, 2012
- Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung CancerJournal of Thoracic Oncology, 2011
- European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung CancerJournal of Clinical Oncology, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJama-Journal Of The American Medical Association, 2010
- Radiation Dose–Volume Effects in the LungInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904Journal of Clinical Oncology, 2010
- Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scanRadiotherapy and Oncology, 2009
- Comparative study of convolution, superposition, and fast superposition algorithms in conventional radiotherapy, three-dimensional conformal radiotherapy, and intensity modulated radiotherapy techniques for various sites, done on CMS XIO planning systemJournal of Medical Physics, 2009
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999